Recommendations from the COST action CA17116 (SPRINT) for the standardization of perinatal derivative preparation and in vitro testing

Recommendations from the COST action CA17116 (SPRINT) for the standardization of perinatal derivative preparation and in vitro testing

Many preclinical studies have shown that birth-associated tissues, cells and their secreted factors, otherwise known as perinatal derivatives (PnD), possess various biological properties that make them suitable therapeutic candidates for the treatment of numerous pathological conditions. Nevertheles...

Full description

Bibliographic Details
Main Authors: Aleksandar Janev, Asmita Banerjee, Adelheid Weidinger, Jure Dimec, Brane Leskošek, Antonietta Rosa Silini, Tina Cirman, Susanne Wolbank, Taja Železnik Ramuta, Urška Dragin Jerman, Assunta Pandolfi, Roberta Di Pietro, Michela Pozzobon, Bernd Giebel, Günther Eissner, Polonca Ferk, Ingrid Lang-Olip, Francesco Alviano, Olga Soritau, Ornella Parolini, Mateja Erdani Kreft
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
standardization
perinatal derivatives
recommendations
CA17116 (SPRINT)
PnD e-questionnaire
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2023.1258753/full

Similar Items

Similar Items